R. Bitterman, M. Paul, D. Polak, Y. Geffen 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors  S. Amit, H. Mishali, T. Kotlovsky,
Benchmarking inappropriate empirical antibiotic treatment
Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study  S. Rhedin, I. Galanis, F. Granath,
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Migrant health—a cause for concern?
Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics  Y.H. van Beurden, S. Nezami,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Refugee crisis and re-emergence of forgotten infections in Europe
Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries  J.A. Otter, N.T. Mutters, E. Tacconelli, A.
R. Cantón  Clinical Microbiology and Infection 
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans?  J.-Y. Madec, M. Haenni, P. Nordmann,
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Do we need new antibiotics?
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Predictors for individual patient antibiotic treatment effect in hospitalized community- acquired pneumonia patients  A.F. Simonetti, C.H. van Werkhoven,
G. Höffken  Clinical Microbiology and Infection 
Isospora belli Clinical Microbiology and Infection
CMI editorial report 2011 Clinical Microbiology and Infection
E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Elements of design: the knowledge on which we build
J. S. Oxford, S. Bossuyt, S. Balasingam, A. Mann, P. Novelli, R
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W
Previously unknown species of Aspergillus
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Benchmarking inappropriate empirical antibiotic treatment
Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study  S. Rhedin, I. Galanis, F. Granath,
Current experience in treating invasive zygomycosis with posaconazole
Reducing antibiotic use in influenza: challenges and rewards
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Morphological changes induced by β-lactam antibiotics observed on Gram staining  R. Bitterman, M. Paul, D. Polak, Y. Geffen  Clinical Microbiology and Infection  Volume 23, Issue 1, (January 2017) DOI: 10.1016/j.cmi.2016.09.026 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Gram stain of Klebsiella pneumoniae during antibiotic treatment. Clinical Microbiology and Infection 2017 23, DOI: (10.1016/j.cmi.2016.09.026) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions